| HOME >> MEDICINE >> TECHNOLOGY |
Table 27: Prostate Cancer, Global, Phase II Pipeline, August 2010 117
Table 28: Prostate Cancer, Global, Phase III Pipeline, August 2010 125
Table 29: Prostate Cancer, Global, Characteristics of Ideal Drug Which Satisfies the Unmet Needs of the Market, 2010 134
Table 30: Prostate Cancer, Global, Description of Ideal Drug Which Satisfies the Unmet Needs of the Market, 2010 135
Table 31: Prostate Cancer, Johnson & Johnson, Oncology Late Stage Pipeline by Indication, 2010 193
Table 32: Prostate Cancer, Global, Auron Healthcare, Key Pipeline Products, 2010 194
Table 33: Prostate Cancer, Global, M&A Deals by Geography, 2010 2041.2
List of FiguresFigure 1: Prostate Cancer Therapeutics Market, Global, Treatment Guidelines, 2010 18
Figure 2: Prostate Cancer Therapeutics Market, Italy, Sales Value ($m), 2001-2009 19
Figure 3: Prostate Cancer Therapeutics Market, Italy, Annual Cost of Therapy ($), 2001-2009 20
Figure 4: Prostate Cancer Therapeutics Market, Italy, Patient Volume ('000s), 2001-2009 22
Figure 5: Prostate Cancer Therapeutics Market, Italy, Treatment Usage Patterns ('000s), 2001-2009 23
Figure 6: Prostate Cancer Therapeutics Market, Italy, Market Drivers and Restraints, 2009 25
Figure 7: Prostate Cancer Therapeutics Market, Italy, Historical Events Impact on the Market, 2010 27
Figure 8: Prostate Cancer Therapeutics Market, Italy, Sales Value ($m), 2009-2020 28
Figure 9: Prostate Cancer Therapeutics Market, Italy, Annual Cost of Therapy ($), 2009-2020 29
Figure 10: Prostate Cancer Therapeutics Market, Italy, Patient Volume ('000s), 2009-2020 30
Figure 11: Prostate Cancer Therapeutics Market, Italy, Treatment Usage Patterns ('000s), 2009-2020 31
Figure 12: Prostate Cancer Therapeutics Market, Italy, Future Market Drivers and Restraints, 2009-2020 33
Figure 13: Prostate Cancer Therapeutics
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |